Recursion Pharmaceuticals, Inc. (RXRX)
3.20
+0.04
(+1.27%)
USD |
NASDAQ |
Sep 11, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Market Cap : 1.709B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.709B |
| September 10, 2026 | 1.688B |
| September 09, 2026 | 1.717B |
| September 08, 2026 | 1.837B |
| September 04, 2026 | 1.939B |
| September 03, 2026 | 1.837B |
| September 02, 2026 | 1.805B |
| September 01, 2026 | 1.779B |
| August 31, 2026 | 1.816B |
| August 28, 2026 | 1.784B |
| August 27, 2026 | 1.837B |
| August 26, 2026 | 1.864B |
| August 25, 2026 | 1.901B |
| August 24, 2026 | 1.736B |
| August 21, 2026 | 1.869B |
| August 20, 2026 | 1.784B |
| August 19, 2026 | 1.869B |
| August 18, 2026 | 1.650B |
| August 17, 2026 | 1.661B |
| August 14, 2026 | 1.688B |
| August 13, 2026 | 1.768B |
| August 12, 2026 | 1.757B |
| August 11, 2026 | 1.789B |
| August 10, 2026 | 1.757B |
| August 07, 2026 | 1.720B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.699B |
| August 05, 2026 | 1.693B |
| August 04, 2026 | 1.768B |
| August 03, 2026 | 1.699B |
| July 31, 2026 | 1.592B |
| July 30, 2026 | 1.613B |
| July 29, 2026 | 1.576B |
| July 28, 2026 | 1.618B |
| July 27, 2026 | 1.597B |
| July 24, 2026 | 1.571B |
| July 23, 2026 | 1.597B |
| July 22, 2026 | 1.581B |
| July 21, 2026 | 1.634B |
| July 20, 2026 | 1.534B |
| July 17, 2026 | 1.563B |
| July 16, 2026 | 1.602B |
| July 15, 2026 | 1.756B |
| July 14, 2026 | 1.772B |
| July 13, 2026 | 1.751B |
| July 10, 2026 | 1.889B |
| July 09, 2026 | 1.995B |
| July 08, 2026 | 1.974B |
| July 07, 2026 | 2.038B |
| July 06, 2026 | 2.101B |
| July 02, 2026 | 2.016B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 7.973B |
| Absci Corp. | 1.408B |
| Novavax, Inc. | 1.553B |
| Editas Medicine, Inc. | 414.53M |
| Amgen, Inc. | 204.00B |
Market Cap Related Metrics
| PS Ratio | 29.69 |
| Price to Book Value | 1.868 |
| Price | 3.20 |
| Earnings Yield | -32.38% |